Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom severity, which is manifested at different phases of infection and demands different levels of care. Viral load, host innate-immune response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricciotti, Emanuela, Laudanski, Krzysztof, FitzGerald, Garret A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280659/
https://www.ncbi.nlm.nih.gov/pubmed/34303107
http://dx.doi.org/10.1016/j.jbior.2021.100818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280659/
https://www.ncbi.nlm.nih.gov/pubmed/34303107
http://dx.doi.org/10.1016/j.jbior.2021.100818

Ejemplares similares